J&J Medical Connect
SYMTUZA®

(darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

SYMTUZA® (darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide)
Medical Information

Repackaging of SYMTUZA

Last Updated: 07/24/2026

SUMMARY

  • No data is available regarding repackaging of SYMTUZA tablets in blister packs or other unit dose containers.
  • No data is available regarding repackaging of SYMTUZA tablets into other containers.
  • No stability data is available for SYMTUZA tablets stored outside of the original container.

Literature Search

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, and DERWENT® (and/or other resources, including internal/external databases) conducted on 03 September 2025. No relevant literature pertaining to this topic was identified.

Would you like to clear and leave your conversation? Message history will be lost.